---
title: "TD Cowen Reaffirms Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287719655.md"
description: "TD Cowen analyst Yaron Werber has reaffirmed a Buy rating on Kailera Therapeutics, Inc. (KLRA), with shares closing at USD21.57. The analyst consensus suggests a Strong Buy rating with an average price target of $39.00, indicating an 80.81% upside. Werber has a 24.3% average return and a 58.70% success rate on his recommendations."
datetime: "2026-05-27T05:15:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287719655.md)
  - [en](https://longbridge.com/en/news/287719655.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287719655.md)
---

# TD Cowen Reaffirms Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)

TD Cowen analyst Yaron Werber maintained a Buy rating on Kailera Therapeutics, Inc. yesterday. The company’s shares closed yesterday at USD21.57.

### Memorial Day Sale – Claim 70% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Werber covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Argenx Se, and Amgen. According to TipRanks, Werber has an average return of 24.3% and a 58.70% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Kailera Therapeutics, Inc. with a $39.00 average price target, which is an 80.81% upside from current levels. In a report released on May 16, William Blair also maintained a Buy rating on the stock with a $0.00 price target.

### Related Stocks

- [KLRA.US](https://longbridge.com/en/quote/KLRA.US.md)
- [TD.US](https://longbridge.com/en/quote/TD.US.md)
- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [Jefferies Sticks to Their Buy Rating for Kailera Therapeutics, Inc. (KLRA)](https://longbridge.com/en/news/287949963.md)
- [Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates | KLRA Stock News](https://longbridge.com/en/news/287673757.md)
- [TD Cowen Sticks to Its Buy Rating for e.l.f. Beauty (ELF)](https://longbridge.com/en/news/287708987.md)
- [Mizuho Securities Sticks to Their Buy Rating for Palvella Therapeutics (PVLA)](https://longbridge.com/en/news/287808371.md)
- [3 High P/E Stocks That Could Surge 30%+](https://longbridge.com/en/news/287789556.md)